Peter C. Brandt - 13 Dec 2023 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
13 Dec 2023
Net transactions value
$0
Form type
4
Filing time
15 Dec 2023, 08:18:28 UTC
Previous filing
16 Jun 2023
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award +81,967 +45% 264,440 13 Dec 2023 Direct F1
holding INAB Common Stock 105,290 13 Dec 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Award +81,967 81,967 13 Dec 2023 Common Stock 81,967 $1.25 Direct F1, F3
transaction INAB Series B Warrants (right to buy) Award +81,967 81,967 13 Dec 2023 Common Stock 81,967 $1.50 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.
F2 The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.
F3 Fully vested and exercisable.